The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use ...

23 NIHR University College London Hospitals Biomedical Research Centre, University College London Hospitals (UCLH) NHS Foundation Trust, London, UK Methods Following the EULAR Standardised Operating ...

The objective of this systematic literature review (SLR) was to obtain an overview of the existing literature on big data in RMDs, to inform a EULAR taskforce.17 In addition, to compare the current ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced key updates on its RESET-Myositis trial and plans for the ...

Credit: Getty Images The EULAR released a 2024 update to the existing guidance on antirheumatic drug use during family planning, pregnancy, breastfeeding, and fertility treatment. The European ...

The US Food and Drug Administration (FDA) has approved Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets) for the treatment of adult patients with KRAS-mutated recurrent low-grade ...

Osteoarthritis is a joint disease causing cartilage breakdown, pain, and stiffness. Management involves personalized plans with lifestyle changes, therapy, and medication. Key management ...

In 2016, EULAR - The European Alliance of Associations for Rheumatology - published points-to-consider on the use of antirheumatic drugs in reproduction, pregnancy, and lactation. Since then ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate ...

Elevate your React Native applications with the power of customizable vector icons. Ideal for embellishing buttons, logos, and navigation or tab bars, these icons seamlessly integrate into your ...

The data is being presented at the 2025 European Alliance of Associations for Rheumatology (EULAR) Annual Congress ... based on the company’s proprietary high-capacity adenovirus vector platform. It ...